Cannabis is becoming much more popular than alcohol among younger cohorts of the US population and regulated sales of marijuana…
McAlinden Research PartnersJune 13, 2022
Publicly-traded cannabis firms' breakout sales growth has largely decoupled from the underperformance of their underlying stock prices over the last month.…
McAlinden Research PartnersAugust 31, 2021
Among the 37 US states that have legalized the distribution of medicinal marijuana, 19 allow the recreational use of cannabis.…
McAlinden Research PartnersJune 30, 2021
New data shows a quarter of Americans now consume cannabis. Nationally, sales are expected to rise to more than $28 billion…
McAlinden Research PartnersMay 11, 2021
Cannabis revenues have soared into 2021 and several key US states are now in the process of legalizing recreational pot sales. In total, 17…
McAlinden Research PartnersApril 12, 2021
On top of significant growth in the North American market, leading cannabis operators are expanding their businesses in Europe this…
McAlinden Research PartnersMarch 11, 2021
Cannabis revenues defied a pandemic in 2020 and are set to move even higher in 2021 with nearly 1 in 3…
McAlinden Research PartnersJanuary 28, 2021
Democrats shored up their hold on the legislative and executive branches of the US government this week, sending cannabis stocks…
McAlinden Research PartnersJanuary 7, 2021
Summary: The cannabis industry received two scoops of good news over the past week as election day saw US voters turn…
McAlinden Research PartnersNovember 9, 2020
